On Friday, Following Stocks were among the “Top 100 Losers” In U.S. Stock Exchange: Arch Coal (NYSE:ACI), Biocept (NASDAQ:BIOC), Macerich (NYSE:MAC), Curis, (NASDAQ:CRIS)
Arch Coal Inc (NYSE:ACI) shares picked down -4.48%, and closed at $0.905. The stock volatility for the week is 12.45%, while for the month remained 9.12%. The company holds consensus target price of $1.70.
If we consider EPS growth of the company, then the company indicated the following observations:
The company showed -2.63 diluted EPS growth for trailing twelve months. However, YTD EPS growth remained 25.10% and Annual EPS growth for the past 5 years is considered as -62.70%.
The mean recommendation of analysts for this stock is 3.30. (Where 1=Buy, 5=Sale).
Arch Coal Inc (ACI) produces and sells thermal and metallurgical coal from surface and underground mines located in the United States. As of December 31, 2014, it operated or contracted out the operation of 16 mines; and owned or controlled approximately 5.1 billion tons of proven and probable recoverable reserves.
Biocept Inc (NASDAQ:BIOC) decreased -4.67%, and closed at $2.45. The stock has price to sale ratio of 391.02. With recent decline, the year-to-date (YTD) performance reflected a 2.51% incline above last year. During the past month the stocks gain 68.97%, bringing three-month performance to -10.58% and six-month performance to -26.43%.
Biocept Inc (BIOC) a cancer diagnostics company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA tests utilizing a standard blood sample. The company’s tests provide information to oncologists that enable them to select the appropriate treatment for their patients based on detailed data on the characteristics of tumors.
Macerich Co (NYSE:MAC) decreased -4.59%, and closed at $89.21. The company holds the market capitalization of $14.11B. For the last twelve months, the stock was able to keep return on equity at 39.40%, while return on assets at 15.00%, in response to its return on investment at 0.50%. Its 20-day moving average gained 0.83%, above 50-day moving average of 2.05%, above 200-day moving average of 21.81% from the latest market price of $89.21. The mean recommendation of analysts for this stock is 3.10. (Where 1=Buy, 5=Sale).
Macerich Co (MAC) is an independent real estate investment trust. The firm invests in the real estate markets of the United States. It primarily engages in acquisition, ownership, development, redevelopment, management and leasing of regional and community shopping centers located throughout the United States.
Curis, Inc. (NASDAQ:CRIS) fell -4.55%, and closed at $2.73. The stock has the beta value of 2.01, and its volatility for the week is 5.87%, while for the month it is 6.71%. The company has the market capitalization of $294.43 million. The company holds the book value per share of 0.35, whereas cash per share is 0.46. Price to book ratio remained 7.80, while price to sale ratio is 30.04. Analysts mean recommendation for the stock is said to be 2.00 (where 1=Buy, 5=sale).
Curis, Inc. (CRIS a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers. The company develops CUDC-907, an oral small molecule inhibitor of histone deacetylase and phosphatidylinositol-3-kinase enzymes, which is in Phase I clinical trials for advanced lymphomas and multiple myeloma; and HER 2-/ ER+ or PR+ breast cancer, and NUT midline carcinoma.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
